<?xml version="1.0" encoding="UTF-8"?>
<results title="binomial">
 <result pre="tivity of hydroxyapatite plant essential oil against Gram-positive bacteria (methicillin-resistant " exact="Staphylococcus aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=" (MRSA) and S. aureus 0364) and Gram-negative bacteria ( Escherichia coli ATCC 25922)" name="binomial"/>
 <result pre=" oil against Gram-positive bacteria (methicillin-resistant Staphylococcus aureus (MRSA) and " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=" 0364) and Gram-negative bacteria ( Escherichia coli ATCC 25922). The samples were studied b" name="binomial"/>
 <result pre="istant Staphylococcus aureus (MRSA) and S. aureus 0364) and Gram-negative bacteria ( " exact="Escherichia coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=" ATCC 25922). The samples were studied by scanning electron microscopy (SEM) and Fourier transform " name="binomial"/>
 <result pre="inhibitory concentration (MIC) related to growth bacteria was 0.039 mg/mL for MRSA, 0.02 mg/mL for " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=" and 0.039 mg/mL E. coli ATCC 25922. The basil EO hydroxyapatite (HAp-B) showed poor inhibit" name="binomial"/>
 <result pre="lated to growth bacteria was 0.039 mg/mL for MRSA, 0.02 mg/mL for S. aureus and 0.039 mg/mL " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=" ATCC 25922. The basil EO hydroxyapatite (HAp-B) showed poor inhibition of bacterial cell growth. T" name="binomial"/>
 <result pre="25 mg/mL for the HAp-B sample in the presence of the MRSA bacteria, 0.313 mg/mL in the presence of " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=" and 0.078 mg/mL for E. coli ATCC 25922. " name="binomial"/>
 <result pre="presence of the MRSA bacteria, 0.313 mg/mL in the presence of S. aureus and 0.078 mg/mL for " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=" ATCC 25922. " name="binomial"/>
 <result pre="he growth of different pathogens. Lavender oil chemical components were proved to be inhibitors of " exact="M. smegmatis" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="M. smegmatis" post=" and E. coli microorganisms [ 8]. Basil oils ( Ocimum ba" name="binomial"/>
 <result pre="athogens. Lavender oil chemical components were proved to be inhibitors of M. smegmatis and " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=" microorganisms [ 8]. Basil oils ( Ocimum basilicum) exhibi" name="binomial"/>
 <result pre="megmatis and E. coli microorganisms [ 8]. Basil oils ( " exact="Ocimum basilicum" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Ocimum basilicum" post=") exhibit antibacterial activity against Brochothrix thermosphacta, E. coli, L. in" name="binomial"/>
 <result pre="terials-11-00652&quot;&gt;8]. Basil oils ( Ocimum basilicum) exhibit antibacterial activity against " exact="Brochothrix thermosphacta" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Brochothrix thermosphacta" post=", E. coli, L. innocua, L. monocytogenes, P. putida, S. typhimurium&lt;/" name="binomial"/>
 <result pre=" Ocimum basilicum) exhibit antibacterial activity against Brochothrix thermosphacta, " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=", L. innocua, L. monocytogenes, P. putida, S. typhimurium, S. putref" name="binomial"/>
 <result pre="icum) exhibit antibacterial activity against Brochothrix thermosphacta, E. coli, " exact="L. innocua" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="L. innocua" post=", L. monocytogenes, P. putida, S. typhimurium, S. putrefaciens and M" name="binomial"/>
 <result pre="ntibacterial activity against Brochothrix thermosphacta, E. coli, L. innocua, " exact="L. monocytogenes" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="L. monocytogenes" post=", P. putida, S. typhimurium, S. putrefaciens and M. flavus microorganis" name="binomial"/>
 <result pre="inst Brochothrix thermosphacta, E. coli, L. innocua, L. monocytogenes, " exact="P. putida" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="P. putida" post=", S. typhimurium, S. putrefaciens and M. flavus microorganisms [ &lt;a href=&quot;#B8-" name="binomial"/>
 <result pre="x thermosphacta, E. coli, L. innocua, L. monocytogenes, P. putida, " exact="S. typhimurium" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus typhimurium" post=", S. putrefaciens and M. flavus microorganisms [ 8]." name="binomial"/>
 <result pre="&gt;E. coli, L. innocua, L. monocytogenes, P. putida, S. typhimurium, " exact="S. putrefaciens" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus putrefaciens" post=" and M. flavus microorganisms [ 8]. " name="binomial"/>
 <result pre=", L. monocytogenes, P. putida, S. typhimurium, S. putrefaciens and " exact="M. flavus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="M. flavus" post=" microorganisms [ 8]. " name="binomial"/>
 <result pre="and lavender (HAp-L) essential oil nanopowders (pressed into pellets) against Gram-positive (MRSA, " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=") and Gram-negative ( E. coli) bacteria was also studied. " name="binomial"/>
 <result pre="opowders (pressed into pellets) against Gram-positive (MRSA, S. aureus) and Gram-negative ( " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=") bacteria was also studied. " name="binomial"/>
 <result pre="The plant EOs used in this study were lavender oil, naturally obtained from " exact="Lavandula angustifolia" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Lavandula angustifolia" post=" L. (Sigma Aldrich, St. Louis, MO, USA), and basil oil, linalol type, obtained from Ocimum basil" name="binomial"/>
 <result pre="ngustifolia L. (Sigma Aldrich, St. Louis, MO, USA), and basil oil, linalol type, obtained from " exact="Ocimum basilicum" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Ocimum basilicum" post=" L. (Sigma Aldrich). The essential oils were used as purchased without any dilution. " name="binomial"/>
 <result pre="croorganism strains that were used in this study were Gram-positive bacteria methicillin-resistant " exact="Staphylococcus aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=" (MRSA) and Staphylococcus aureus 0364 ( S. aureus 0364) and Gram-negative bacteria &lt;" name="binomial"/>
 <result pre="is study were Gram-positive bacteria methicillin-resistant Staphylococcus aureus (MRSA) and " exact="Staphylococcus aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=" 0364 ( S. aureus 0364) and Gram-negative bacteria Escherichia coli ATCC 25922, ( " name="binomial"/>
 <result pre=" methicillin-resistant Staphylococcus aureus (MRSA) and Staphylococcus aureus 0364 ( " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=" 0364) and Gram-negative bacteria Escherichia coli ATCC 25922, ( E. coli ATCC 25922)." name="binomial"/>
 <result pre="&gt; (MRSA) and Staphylococcus aureus 0364 ( S. aureus 0364) and Gram-negative bacteria " exact="Escherichia coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=" ATCC 25922, ( E. coli ATCC 25922). The qualitative antibacterial assays were performed usin" name="binomial"/>
 <result pre="/i&gt; 0364 ( S. aureus 0364) and Gram-negative bacteria Escherichia coli ATCC 25922, ( " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=" ATCC 25922). The qualitative antibacterial assays were performed using microbial suspensions obtai" name="binomial"/>
 <result pre="sil and lavender samples was assessed using Methicillin-Resistant Staphylococcus aureus (MRSA) and " exact="Staphylococcus aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=" 0364 ( S. aureus 0364) and Gram-negative bacteria, Escherichia coli ATCC 25922, ( &lt;i" name="binomial"/>
 <result pre="d using Methicillin-Resistant Staphylococcus aureus (MRSA) and Staphylococcus aureus 0364 ( " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=" 0364) and Gram-negative bacteria, Escherichia coli ATCC 25922, ( E. coli ATCC 25922)" name="binomial"/>
 <result pre=" (MRSA) and Staphylococcus aureus 0364 ( S. aureus 0364) and Gram-negative bacteria, " exact="Escherichia coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=" ATCC 25922, ( E. coli ATCC 25922) bacterial strains. The qualitative antibacterial results " name="binomial"/>
 <result pre="i&gt; 0364 ( S. aureus 0364) and Gram-negative bacteria, Escherichia coli ATCC 25922, ( " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=" ATCC 25922) bacterial strains. The qualitative antibacterial results of the tested samples obtaine" name="binomial"/>
 <result pre="The results indicated that HAp-L displayed good antibacterial activity against MRSA, " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=" 0364 and E. coli ATCC 25922 microbial strains, while the antibacterial activity of HAp-B sa" name="binomial"/>
 <result pre="indicated that HAp-L displayed good antibacterial activity against MRSA, S. aureus 0364 and " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=" ATCC 25922 microbial strains, while the antibacterial activity of HAp-B samples against MRSA, S" name="binomial"/>
 <result pre=" ATCC 25922 microbial strains, while the antibacterial activity of HAp-B samples against MRSA, " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=" 0364 and E. coli ATCC 25922 was not so well evidenced. It can be observed that HAp-L was st" name="binomial"/>
 <result pre="strains, while the antibacterial activity of HAp-B samples against MRSA, S. aureus 0364 and " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=" ATCC 25922 was not so well evidenced. It can be observed that HAp-L was strongly inhibitory agains" name="binomial"/>
 <result pre="0652-f007&quot;&gt;Figure 7c,f,i). The results also suggested that HAp-B was moderately inhibitory against " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=" 0364 ( Figure 7h) and weakly inhibitory to MRSA, ( &lt;a href=&quot;#ma" name="binomial"/>
 <result pre="als-11-00652-f007&quot;&gt;Figure 7b). The HAp-B sample showed the best antimicrobial activity against the " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=" ATCC 25922 bacterial strain ( Figure 7e). Due to the fact that " name="binomial"/>
 <result pre=" cinnamon, clove, pimento, thyme, oregano, and rosemary have been reported to be effective against " exact="Salmonella typhi" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Salmonella typhi" post=" (Gram negative), Staphylococcus aureus (Gram positive), and Pseudomonas aeruginosa (" name="binomial"/>
 <result pre=", and rosemary have been reported to be effective against Salmonella typhi (Gram negative), " exact="Staphylococcus aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=" (Gram positive), and Pseudomonas aeruginosa (Gram negative) bacterial strains [ &lt;a href=&quot;#B" name="binomial"/>
 <result pre="against Salmonella typhi (Gram negative), Staphylococcus aureus (Gram positive), and " exact="Pseudomonas aeruginosa" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Pseudomonas aeruginosa" post=" (Gram negative) bacterial strains [ 35]. Moreover, Myrtus com" name="binomial"/>
 <result pre="eruginosa (Gram negative) bacterial strains [ 35]. Moreover, " exact="Myrtus communis" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Myrtus communis" post=" EO has been described as being effective in the case of S. aureus, L. monocytogenes," name="binomial"/>
 <result pre="652&quot;&gt;35]. Moreover, Myrtus communis EO has been described as being effective in the case of " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=", L. monocytogenes, Enterococcus durans, B. subtilis, Mycobacterium tuberculosis&lt;/" name="binomial"/>
 <result pre=", Myrtus communis EO has been described as being effective in the case of S. aureus, " exact="L. monocytogenes" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Lavandula monocytogenes" post=", Enterococcus durans, B. subtilis, Mycobacterium tuberculosis, P. aeruginosa," name="binomial"/>
 <result pre="EO has been described as being effective in the case of S. aureus, L. monocytogenes, " exact="Enterococcus durans" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Enterococcus durans" post=", B. subtilis, Mycobacterium tuberculosis, P. aeruginosa, S. typhi, E. coli" name="binomial"/>
 <result pre="&gt;L. monocytogenes, Enterococcus durans, B. subtilis, Mycobacterium tuberculosis, " exact="P. aeruginosa" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Pseudomonas aeruginosa" post=", S. typhi, E. coli, K. pneumoniae, and Mycobacterium avium bacterial s" name="binomial"/>
 <result pre=" Enterococcus durans, B. subtilis, Mycobacterium tuberculosis, P. aeruginosa, " exact="S. typhi" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus typhi" post=", E. coli, K. pneumoniae, and Mycobacterium avium bacterial strains, which bel" name="binomial"/>
 <result pre="durans, B. subtilis, Mycobacterium tuberculosis, P. aeruginosa, S. typhi, " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=", K. pneumoniae, and Mycobacterium avium bacterial strains, which belong both to the " name="binomial"/>
 <result pre=". subtilis, Mycobacterium tuberculosis, P. aeruginosa, S. typhi, E. coli, " exact="K. pneumoniae" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="K. pneumoniae" post=", and Mycobacterium avium bacterial strains, which belong both to the Gram-negative as well " name="binomial"/>
 <result pre="tuberculosis, P. aeruginosa, S. typhi, E. coli, K. pneumoniae, and " exact="Mycobacterium avium" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Mycobacterium avium" post=" bacterial strains, which belong both to the Gram-negative as well as the Gram-positive bacterial s" name="binomial"/>
 <result pre="vender EO, which was demonstrated to exhibit in vitro activity against MRSA (methicillin-resistant " exact="Staphylococcus aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=") even at low concentrations [ 38, &lt;a href=&quot;#B39-materials-11-006" name="binomial"/>
 <result pre="extracted from oregano, basil, and coriander plants exhibit a noticeable inhibitory effect against " exact="P. aeruginosa" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Pseudomonas aeruginosa" post=", S. aureus, and Yersinia enterocolitica even at low concentrations. On the other han" name="binomial"/>
 <result pre=", basil, and coriander plants exhibit a noticeable inhibitory effect against P. aeruginosa, " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=", and Yersinia enterocolitica even at low concentrations. On the other hand, M. Sienkiewicz " name="binomial"/>
 <result pre=" plants exhibit a noticeable inhibitory effect against P. aeruginosa, S. aureus, and " exact="Yersinia enterocolitica" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Yersinia enterocolitica" post=" even at low concentrations. On the other hand, M. Sienkiewicz et al. [ &lt;a href=&quot;#B41-materials-11-" name="binomial"/>
 <result pre="ctive antibacterial agents, reported that basil EO exhibited strong antibacterial activity against " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=" clinical strains. " name="binomial"/>
 <result pre="f=&quot;#B42-materials-11-00652&quot;&gt;42] identified a zone with an average inhibition diameter of 23 mm for " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=" ATCC 25922 when tested against antibiotic discs of tetracycline (30 µg). More than that, the antib" name="binomial"/>
 <result pre=" types of MRSA was tested with tetracycline antibiotic discs (30 μg). The antibiotic resistance of " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=" control strains against antibiotic discs of tetracycline (30 µg) has also been tested previously [" name="binomial"/>
 <result pre="p-L ranged from no inhibition for HAp sample to 25.83 ± 0.9 mm for the HAp-L sample in the case of " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=" 0364 bacterial strain. The results suggested that HAp-L presented a stronger antibacterial activit" name="binomial"/>
 <result pre="nger antibacterial activity against all tested microbial strains. In the case of HAp-B sample, the " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=" bacterial strain proved to be the most susceptible, presenting a diameter inhibition zone of 14.65" name="binomial"/>
 <result pre=" of nanopowders of hydroxyapatite coated with basil (HAp-B) and lavender (HAp-L) EOs against MRSA, " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=" and E. coli bacterial strains ( Figure 8). " name="binomial"/>
 <result pre="droxyapatite coated with basil (HAp-B) and lavender (HAp-L) EOs against MRSA, S. aureus and " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=" bacterial strains ( Figure 8). " name="binomial"/>
 <result pre="anopowders of HAp-B and HAp-L on cell viability was appraised on different Gram-positive (MRSA and " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=") and Gram-negative ( E. coli) bacteria ( Figure 8a–c). T" name="binomial"/>
 <result pre="viability was appraised on different Gram-positive (MRSA and S. aureus) and Gram-negative ( " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=") bacteria ( Figure 8a–c). The effects of the HAp-B and HAp-L sa" name="binomial"/>
 <result pre=" 0.625 mg/mL, HAp-B did not have any effect on the inhibition of MRSA cell growth. An evolution of " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=" cell growth in the presence of the HAp-B and HAp-L was also monitored ( &lt;a href=&quot;#materials-11-006" name="binomial"/>
 <result pre=" HAp-L was also monitored ( Figure 8b). Impaired cell growth of " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=" was observed at concentrations between 0.313 and 5 mg/mL for the HAp-B sample. Likewise, a decreas" name="binomial"/>
 <result pre="centrations between 0.313 and 5 mg/mL for the HAp-B sample. Likewise, a decrease in cell growth of " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=" was observed, starting at the lowest concentration (0.01 mg/mL), in the presence of the HAp-B samp" name="binomial"/>
 <result pre="Ap-B sample. Additionally, the inhibitory effect of the HAp-B and HAp-L was also evaluated against " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=" bacterial cells ( Figure 8c). The HAp-L inhibited the E. col" name="binomial"/>
 <result pre=" coli bacterial cells ( Figure 8c). The HAp-L inhibited the " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=" growth starting with a concentration equal to 0.02 mg/mL while the HAp-B inhibited the E. coli&lt;" name="binomial"/>
 <result pre="E. coli growth starting with a concentration equal to 0.02 mg/mL while the HAp-B inhibited the " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=" growth starting with a concentration equal to 0.078 mg/mL. " name="binomial"/>
 <result pre="the HAp-B sample related to the MRSA was 0.625 mg/mL. On the other hand, the visible inhibition of " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=" bacterial growth was observed at 0.02 mg/mL for the HAp-L sample. The value of MIC related to the " name="binomial"/>
 <result pre=" growth was observed at 0.02 mg/mL for the HAp-L sample. The value of MIC related to the growth of " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=" bacteria was registered at 0.313 mg/mL for the HAp-B sample. For HAp-L, a clear inhibition of E" name="binomial"/>
 <result pre=" bacteria was registered at 0.313 mg/mL for the HAp-B sample. For HAp-L, a clear inhibition of " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=" bacterial growth at 0.039 mg/mL was observed, but the MIC value was recorded at 0.02 mg/mL. The MI" name="binomial"/>
 <result pre="rowth at 0.039 mg/mL was observed, but the MIC value was recorded at 0.02 mg/mL. The MIC value for " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=" bacterial growth was recorded at 0.078 mg/mL for the HAp-B sample. According to Tripathi [ &lt;a href" name="binomial"/>
 <result pre="n that leads to microbial death. In agreement with Tripathi, the MBC values at which the growth of " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=" and E. coli was stopped by HAp-L were at concentrations of 1.25 mg/mL. On the other hand, T" name="binomial"/>
 <result pre="bial death. In agreement with Tripathi, the MBC values at which the growth of S. aureus and " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=" was stopped by HAp-L were at concentrations of 1.25 mg/mL. On the other hand, Taylor et al. [ &lt;a h" name="binomial"/>
 <result pre="2&quot;&gt;48], in their studies on &quot;determination of minimum bactericidal concentrations of oxacillin for " exact="Staphylococcus aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=": influence and significance of technical factors&quot;, defined MBC as the smallest concentration that " name="binomial"/>
 <result pre="nkey and Sabath [ 49], the MBC value at which the development of " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=" and E coli bacterial cells was stopped in the presence of HAp-L was 0.625 mg/mL. For MRSA, " name="binomial"/>
 <result pre="0652&quot;&gt;49]. A slight decrease in the cellular viability of various Gram-positive bacteria (MRSA and " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=") and Gram-negative ( E. coli) in the presence of HAp-B was evidenced without any reduction " name="binomial"/>
 <result pre="llular viability of various Gram-positive bacteria (MRSA and S. aureus) and Gram-negative ( " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=") in the presence of HAp-B was evidenced without any reduction in cellular development by 99.9%. " name="binomial"/>
 <result pre="ood antimicrobial activity. HAp-L and HAp-B were found to be effective in inhibiting the growth of " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=", E coli and MRSA bacterial strains. The results of this study suggested that the best antib" name="binomial"/>
 <result pre="Qualitative assay of the inhibitory activity of HAp, HAp-B and HAp-L samples against MRSA ( a– c), " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=" ATCC 25922 ( d– f) and S. aureus 0364 ( g– i) bacterial strains. " name="binomial"/>
 <result pre="tivity of HAp, HAp-B and HAp-L samples against MRSA ( a– c), E. coli ATCC 25922 ( d– f) and " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=" 0364 ( g– i) bacterial strains. " name="binomial"/>
 <result pre="nce of the plant EO-coated HAp (HAp-B and HAp-L) on different bacterial strains such as MRSA ( a), " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=" ( b) and E. coli ( c), quantified by the A620 nm values. " name="binomial"/>
 <result pre=" HAp (HAp-B and HAp-L) on different bacterial strains such as MRSA ( a), S. aureus ( b) and " exact="E. coli" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Escherichia coli" post=" ( c), quantified by the A620 nm values. " name="binomial"/>
 <result pre="Inhibition zone diameters of HAp, HAp-B and HAp-L samples against MRSA, " exact="S. aureus" xpath="/html[1]/body[1]/div[4]/div[12]/p[1]" match="Staphylococcus aureus" post=" 0364 and E. coli ATCC 25922 bacterial strains. " name="binomial"/>
 <result pre="Inhibition zone diameters of HAp, HAp-B and HAp-L samples against MRSA, S. aureus 0364 and " exact="E. coli" match="Escherichia coli" post=" ATCC 25922 bacterial strains. " name="binomial"/>
</results>
